US4390023A - Patterned electrical tissue stimulator - Google Patents

Patterned electrical tissue stimulator Download PDF

Info

Publication number
US4390023A
US4390023A US06/259,099 US25909981A US4390023A US 4390023 A US4390023 A US 4390023A US 25909981 A US25909981 A US 25909981A US 4390023 A US4390023 A US 4390023A
Authority
US
United States
Prior art keywords
current
stimulation
electrodes
pulses
electrode
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US06/259,099
Inventor
Mark T. Rise
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medtronic Inc
Original Assignee
Medtronic Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
US case filed in Delaware District Court litigation Critical https://portal.unifiedpatents.com/litigation/Delaware%20District%20Court/case/1%3A18-cv-00644 Source: District Court Jurisdiction: Delaware District Court "Unified Patents Litigation Data" by Unified Patents is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Medtronic Inc filed Critical Medtronic Inc
Priority to US06/259,099 priority Critical patent/US4390023A/en
Assigned to MEDTRONIC, INC. reassignment MEDTRONIC, INC. ASSIGNMENT OF ASSIGNORS INTEREST. Assignors: RISE MARK T.
Application granted granted Critical
Publication of US4390023A publication Critical patent/US4390023A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/36014External stimulators, e.g. with patch electrodes
    • A61N1/36021External stimulators, e.g. with patch electrodes for treatment of pain

Definitions

  • the invention pertains to the field of nerve stimulators used in the field of medicine for the relief of pain. More particularly, the invention relates to an automatically controlled electrical tissue stimulator for use with a multiple electrode system for generating spatially and temporally patterned electrical nerve stimulation.
  • Electrical nerve stimulators have become widely used in recent years in the field of medicine for the treatment of chronic intractable pain. Such devices include circuitry for generating electrical pulses, and electrode leads for delivering the pulses to the site of pain within the body.
  • the electrical stimulating pulses produce the effect of masking the sensation of pain, and this method is preferable to drug therapy for many types of pain, because it avoids subjecting the patient to possible dangerous side effects.
  • adjustments or controls so that the stimulation delivered by the device can be adjusted or controlled according to the needs of the patient, which sometimes vary from day to day, or even minute to minute.
  • the stimulus repetition rate, the stimulus intensity, and the stimulus situs should be controllable to provide maximum flexibility in meeting the patient's needs.
  • Transcutaneous stimulators are worn or carried outside the body and have electrodes secured to the skin over the affected area to apply the electrical stimulation thereto.
  • transcutaneous stimulators comprise a set of electrodes or an electrode pair with leads connected to a portable controller, with adjustments for stimulus frequency and intensity.
  • Electrical stimulation is generally provided with pulses that may be adjusted for varying frequency, width, or amplitude.
  • monophasic and bi-phasic type pulses are generally used.
  • Monophasic type pulses induce current in the body tissue that flows in only one direction, the electrodes having a fixed polarity. It is generally known in the art that monophasic pulses of this type produce a "stinging" sensation or pain for the patient.
  • the bi-phasic pulse is comprised of two sequential monophasic pulses of alternating polarity. In this manner, electrical nerve stimulation may be produced without a net DC current, thus avoiding the "stinging" pain associated with it.
  • the technique of temporal integration or temporal summation is also known in the art.
  • two or more threshold or sub-threshold stimulation pulses are delivered to the body tissue in a sufficiently short period of time so that they are summed or integrated to produce a discernible stimulus.
  • pulse trains will be referred to as pulse bursts.
  • the technique is advantageous in that a series of relatively low amplitude pulses (approximately 5 milliamps or less) may be used to produce stimulation requiring 80 milliamps or more using the single pulse stimulation method.
  • the advantage comes from being able to use a standard FET current source as opposed to the fly back transformer or pulse transformer current source most commonly used in the single pulse method and from the reduced likelihood of the patient's experiencing "stinging pain”.
  • stimulation pulses are delivered to body tissue through one pair of electrodes.
  • each electrode has an area on the order of 4.5 square inches. While this method is advantageous because of its simplicity, it is hindered by its poor ability to distribute current uniformly throughout the volume of tissue beneath and between electrode pads. The problem is generally attributed to the varying conductivity of the tissue and the tissueelectrode interface. Usually, local tissue breakdown results in a single isolated current path from one electrode to the other. Through the use of a multiple electrode system where each electrode has an area on the order of 10 square millimeters, this problem has been alleviated. However, to operate a multiple electrode system using the conventional single pulse method, it is necessary that each electrode pair have an independent current source.
  • the multiple electrode system may be used to generate spatial patterns of stimulation.
  • Such a prior art device exists, using switches to manually select spatially separated electrode pairs.
  • pulse width and pulse amplitude provide control over perceived stimulus intensity
  • controlling the pulse rate may also improve the efficacy of stimulation.
  • Many prior art devices provide adjustable pulse rate with a manual control. While such manual control provides the patient with a means for varying the stimulus perception when any particular pulse rate becomes painful, annoying, or imperceptible, the method usually requires that the patient adjust the pulse rate regularly. This is sometimes impracticable, i.e., if the patient is sleeping or his hands are immobile.
  • Much of the difficulty associated with manual adjustment of pulse rate has been overcome through the use of automatic controls that vary the pulse rate randomly or rhythmically, such as the 1/f fluctuation technique. Findings have shown that such methods are also more effective in alleviating pain.
  • the present invention is an apparatus and method for producing patterned electrical tissue stimulation comprising a current generation means connected through a multiplexing means to a plurality of electrodes, the multiplexing means and the current means being connected to a control means, whereby electrical tissue stimulation is produced.
  • FIG. 1 is a block diagram of a Patterned Electrical Nerve Stimulator according to the present invention.
  • FIG. 2 is an illustration of possible electrode placement on a patient
  • FIGS. 3, 3a, 3b, and 3c are a flow chart of the software according to the present invention.
  • the invention as embodied in the block diagram of FIG. 1 comprises seven principal components: user interface 150, microprocessor 100, data latch 105, analog multiplexers 110 and 115, analog switch 120, and constant current source 125.
  • microcomputer 100 functions as the controller for elements 110, 115, and 120. While the embodiment shown in FIG. 1 utilizes an 1802 type microcomputer, any microcomputer or custom designed controller chip capable of performing the necessary functions may be substituted.
  • User interface 150 which is connected to microprocessor 100 through multi-line connector 155, provides for on/off and stimulus intensity control.
  • Data latch 105 is connected to microcomputer 100 through data bus 103. It serves to store and synchronize output data from microcomputer 100 for control of analog multiplexers 110 and 115. Data buses 107 and 108 carry control data out of data latch 105 into analog multiplexers 110 and 115, respectively. Buses 107 and 108 each comprise four individual data lines which deliver multiplexing information to analog multiplexers 110 and 115.
  • Analog multiplexers 110 and 115 provide for a 1 to 16 multiplex.
  • Output lines 112 and 117 are connected through a suitable conductor arrangement 170 so that either input lines 111 or 116 to the respective analog multiplexers 110 and 115 may be connected to any of the 16 electrodes 200 (only eight are depicted) as shown in FIG. 2. While the embodiment shown in FIG. 1 features a dual 1 to 16 multiplexing system, it will be seen that minor modifications would provide for a lesser or greater multiplexing capability.
  • the inputs to analog multiplexers 110 and 115 are connected through conductors 113 and 118 to the respective outputs 114 and 119 of analog switch 120.
  • Microprocessor Q line output 144 controls analog switch 120 so that outputs 114 and 119 may be connected to inputs 132 and 130, respectively, or 130 and 132, respectively.
  • On/off control of analog switch 120 is provided for by line 148 to microprocessor 100.
  • Inputs 132 and 130 are connected through conductors 140 and 138 to respective outputs 134 and 136 of constant current source 125. As illustrated, outputs 134 and 136 of constant current source 125 have the respective polarities of positive and negative. In the described configuration it will be seen that the polarity of outputs 114 and 119 toggle or alternate in response to signals input from Q line 144 to analog switch 120.
  • electrode array 200 comprises 16 independent transcutaneous electrodes each with an area on the order of 10 square millimeters.
  • electrode array 200 may be comprised of subcutaneous electrodes.
  • the electrodes comprising array 200 may be of any type generally known in the art, only reduced in size.
  • Each electrode in the array has two connections, one to a corresponding output 112 of multiplexer 110 and the other to the corresponding output 117 of multiplexer 115.
  • electrode 235 would be connected to analog multiplexers 110 and 115 at each respective "1" output. This allows for any two electrodes in array 200 to be selected as a stimulus pair.
  • the electrodes comprising electrode array 200 may be secured to (or in) the patient's body to form any desirable arrangement.
  • the electrodes may be arranged in groups of four (210) or in a line (215). In any event, it is generally known in the art that a minimum spacing of approximately one to two inches is necessary in order for the patient to perceive a spatial separation of stimulus origin.
  • the tissue below the perimeter defined by electrodes 235, 220, 225, and 230 (as shown in FIG. 2) is sought to be electrically stimulated. As will be explained later (in the software discussion), this task may be performed in the system's "immediate" mode.
  • the four electrodes i.e., 235, 220, 225, and 230
  • the four electrodes may be paired to form up to six independent combinations.
  • stimulation pulses delivered to any of the six possible pairs within a 4 millisecond period will be temporally indistinguishable to the patient. Due to circuit and technique limitations in the particular embodiment shown as hereinafter described, a maximum of four pairs of electrodes may be pulsed within any given 4 millisecond period. For this example, assume the four electrode pairs 235 and 230, 220 and 225, 220 and 230, and 235 and 225 will be sequentially pulsed so as to blend the four pulse bursts into a single perceived stimulation event.
  • the first step in accomplishing the desired stimulation is connecting constant current source 125 outputs 134 and 136 to the first pair of electrodes 235 and 230, respectively.
  • microprocessor 100 loads the proper multiplexing data into data latch 105 through data bus 103.
  • This multiplex code is then conducted to multiplexers 110 and 115 through data buses 107 and 108, respectively, resulting in the connection of electrodes 235 and 230 to inputs 111 and 116. In the preferred embodiment, this sequence of events takes about 50 microseconds.
  • electrical tissue stimulation is produced by constant current source 125 and analog switch 120.
  • Constant current source 125 produces a constant current of up to 5 milliamps between its outputs 134 and 136 given any reactance less than 2.5 kilohms.
  • microprocessor Q line output 144 is used to toggle analog switch 120 so that bi-phasic pulses with a current amplitude of approximately 2-4 milliamps and a period of approximately 80 microseconds are delivered to the selected electrode pair.
  • each individual bi-phasic pulse is marginally perceptible, a series of two or more produce an easily discernible effect. In the present example, approximately ten such pulses could be sequentially delivered to the electrode pair 235 and 213, consuming a total time interval of approximately 800 microseconds.
  • microprocessor 100 After delivering up to ten bi-phasic pulses to the first selected electrode pair, microprocessor 100 automatically connects the next pair. It will be seen that the total elapsed time between the connection of the first electrode pair, the subsequent pulsing, and the connection to the second electrode pair will be no more than 1 millisecond. In this manner, four distinct stimuli (pulse bursts) may be used to produce what is perceived by the patient as a single stimulation event or pulse. This technique provides a major advantage over the conventional two electrode system in that it can greatly enhance tissue current distribution without altering the patient's stimulus perception.
  • Initialize block 310 represents the functions performed by the microprocessor at the outset of each use. Initialize functions include, but are not limited to, such things as clearing data latches and presetting program counters.
  • Flow chart box 320 represents the software code which retrieves stimulation instructions from memory chips such as EPROMS or ROMS. In the present embodiment these instructions are stored in two eight-bit words, one word containing the electrode pair choice and the other word frequency-duratin code. The frequency code controls the time between stimulation bursts (stimulation frequency), while the duration code controls the length of time between changes in the stimulation frequency. The stimulation frequency and its duration are both programmable.
  • the former from 2 to 500 Hz and the latter from 500 milliseconds to 10 seconds.
  • the software which decodes these eight-bit words into usable form is represented by box 325. Using a standard 4k ROM, it will be seen that up to 10 hours of continuously varying stimulation can be accomplished.
  • user interface 150 includes two buttons for control of stimulus intensity.
  • microprocessor 100 presets the intensity control value to its minimum setting.
  • Flow chart block 330 corresponds to the software which retrieves this intensity value from memory for use during the stimulation process.
  • the intensity value controls the quantity of sequential bi-phasic pulses delivered during each pulse burst.
  • Block 335 represents the software which places the intensity value retrieved from the memory into an intensity pulse counter. The compliment of this value is then loaded into the intensity pulse compensation counter (block 340). After these counters have been loaded, data latch 105 is loaded with the eight bits corresponding to the two selected electrodes (block 345).
  • the software (indicated by block 350) then initiates the electrical nerve stimulation process by enabling analog switch 120.
  • Flow chart boxes 355-390 represent the software which produces bursts of bi-phasic pulses and the corresponding delays thereafter. Basically, a series of bi-phasic pulses is produced and then followed by a complementary delay period so as to maintain a uniform operational delay for all possible stimulation intensity levels. After each such burst is complete, the decoded frequency (decoded in box 325) is retrieved from the memory and analyzed by the software corresponding to box 400. This analysis reveals either a programmed delay or an "immediate” mode command.
  • the "immediate” mode "if” statement in box 400 provides the means whereby the system can switch immediately to another electrode pair without a delay (e.g., as described in the illustrative example). If in the "immediate” mode the software relating to block 400 directs the microprocessor 100 to block 320, where the next segment of stimulation data is read from the memory.
  • the program When not in the "immediate” mode, the program advances to flow chart block 405, where the software represented thereby converts the frequency to an appropriate delay count.
  • the software corresponding to block 410 interrogates the duration counter for decision in block 415. If the duration counter is equal to zero the program advances to block 420 where the duration code is converted to appropriate duration count. If the duration counter is not at zero, the program advances to software block 425, which comprises a software delay designed to simulate the delay introduced by block 420. From both blocks 420 and 425 the program advances to the software represented by blocks 430 through 450.
  • the software represented by these blocks comprises the microprocessor 100 user interface 150 interrogation routine. This routine involves sensing the stimulation buttons on user interface 150.
  • the software will adjust the intensity value accordingly providing there have been no changes within the last three seconds (block 440). If neither button is depressed, the program will jump from block 430 to block 445.
  • Program flow chart boxes 445 allow the pattern source to be altered during operation. For example, a patient may have several alternative patterns to choose from. These patterns may be in one master ROM or several smaller ones.
  • the program begins to loop through blocks 455 to 470. This routine provides for the delay from each stimulation burst to the next and for control of the duration of the stimulation frequency In the case where the duration period is incomplete, box 475 directs the program flow back to box 330 to reinitiate the process which begins therefrom.
  • box 475 directs the program flow to box 320 where new instructions are read from the memory and the stimulation process is reinitiated. While the foregoing program flow chart description describes in adequate detail the interaction and operation of the software of the present invention, it will be observed that other programs which adequately perform these and other tasks may be substituted.
  • spatially modulated or patterned stimulation can be accomplished by changing the stimulating electrode pair or pairs every so often as necessary to produce a traveling stimulus sensation to the patient.
  • the frequency of stimulation may be varied automatically (by varying the duration code) so as to provide any known type of temporal variations (e.g., 1/f, rhythmic, random, or progressive).
  • These spatial and temporal patterns are easily programmed into the memory media directly (e.g., using a PROM burner) or through any higher level software systems adapted for such use.
  • the capability to spatially and temporally modulate the electrical stimulus provides the means to overcome the problems normally associated with electrical nerve stimulation. For example, the habituation effects caused by excessive stimulation to any particular tissue situs or that induced by monotony of stimulation frequency and intensity. Furthermore, the present invention provides the means for ready adaptation of electrical stimulus technique so that a wide variety of patient needs may be satisfied. ##SPC1##

Abstract

A patterned electrical tissue stimulator includes a current source and analog multiplexers connected to an array of electrodes attached to the body. Microprocessor control of the multiplexer and the current source provides automatic selection of electrode stimulation pairs whereby spatial patterns of electrical stimulation are produced. Temporal summation and temporal patterns of electrical stimulus are provided through microprocessor control of the current source.

Description

TECHNICAL FIELD OF THE INVENTION
The invention pertains to the field of nerve stimulators used in the field of medicine for the relief of pain. More particularly, the invention relates to an automatically controlled electrical tissue stimulator for use with a multiple electrode system for generating spatially and temporally patterned electrical nerve stimulation.
BACKGROUND OF THE INVENTION
Electrical nerve stimulators have become widely used in recent years in the field of medicine for the treatment of chronic intractable pain. Such devices include circuitry for generating electrical pulses, and electrode leads for delivering the pulses to the site of pain within the body. The electrical stimulating pulses produce the effect of masking the sensation of pain, and this method is preferable to drug therapy for many types of pain, because it avoids subjecting the patient to possible dangerous side effects. In the control of chronic pain by a nerve stimulator, there are generally provided adjustments or controls so that the stimulation delivered by the device can be adjusted or controlled according to the needs of the patient, which sometimes vary from day to day, or even minute to minute. Ideally, the stimulus repetition rate, the stimulus intensity, and the stimulus situs should be controllable to provide maximum flexibility in meeting the patient's needs. Transcutaneous stimulators are worn or carried outside the body and have electrodes secured to the skin over the affected area to apply the electrical stimulation thereto. Generally, transcutaneous stimulators comprise a set of electrodes or an electrode pair with leads connected to a portable controller, with adjustments for stimulus frequency and intensity. Electrical stimulation is generally provided with pulses that may be adjusted for varying frequency, width, or amplitude. In the prior art, monophasic and bi-phasic type pulses are generally used.
Monophasic type pulses induce current in the body tissue that flows in only one direction, the electrodes having a fixed polarity. It is generally known in the art that monophasic pulses of this type produce a "stinging" sensation or pain for the patient. The bi-phasic pulse is comprised of two sequential monophasic pulses of alternating polarity. In this manner, electrical nerve stimulation may be produced without a net DC current, thus avoiding the "stinging" pain associated with it.
While the most common method of controlling stimulation intensity is varying the pulse width or amplitude, the technique of temporal integration or temporal summation is also known in the art. To achieve varying degrees of stimulation intensity using temporal summation, two or more threshold or sub-threshold stimulation pulses are delivered to the body tissue in a sufficiently short period of time so that they are summed or integrated to produce a discernible stimulus. Hereinafter these "pulse trains" will be referred to as pulse bursts. The technique is advantageous in that a series of relatively low amplitude pulses (approximately 5 milliamps or less) may be used to produce stimulation requiring 80 milliamps or more using the single pulse stimulation method. Specifically, the advantage comes from being able to use a standard FET current source as opposed to the fly back transformer or pulse transformer current source most commonly used in the single pulse method and from the reduced likelihood of the patient's experiencing "stinging pain".
In a conventional electrical nerve stimulation system, stimulation pulses are delivered to body tissue through one pair of electrodes. Generally, each electrode has an area on the order of 4.5 square inches. While this method is advantageous because of its simplicity, it is hindered by its poor ability to distribute current uniformly throughout the volume of tissue beneath and between electrode pads. The problem is generally attributed to the varying conductivity of the tissue and the tissueelectrode interface. Usually, local tissue breakdown results in a single isolated current path from one electrode to the other. Through the use of a multiple electrode system where each electrode has an area on the order of 10 square millimeters, this problem has been alleviated. However, to operate a multiple electrode system using the conventional single pulse method, it is necessary that each electrode pair have an independent current source. This is generally impractical in a portable system because of space and weight limitations. In addition to providing for better current distribution in the stimulated tissue, the multiple electrode system may be used to generate spatial patterns of stimulation. Such a prior art device exists, using switches to manually select spatially separated electrode pairs.
While pulse width and pulse amplitude provide control over perceived stimulus intensity, it is well known that controlling the pulse rate may also improve the efficacy of stimulation. Many prior art devices provide adjustable pulse rate with a manual control. While such manual control provides the patient with a means for varying the stimulus perception when any particular pulse rate becomes painful, annoying, or imperceptible, the method usually requires that the patient adjust the pulse rate regularly. This is sometimes impracticable, i.e., if the patient is sleeping or his hands are immobile. Much of the difficulty associated with manual adjustment of pulse rate has been overcome through the use of automatic controls that vary the pulse rate randomly or rhythmically, such as the 1/f fluctuation technique. Findings have shown that such methods are also more effective in alleviating pain. See Pain Control by Transcutaneous Electrical Nerve Stimulating Using Irregular Pulse of 1/f Fluctuation, Kintomo Takakura, Keiji Sano, Yukio Kosugi & Jyun Ikebe, Applied Neurophysiology, D. 42, 1979, page 314. The efficacy of electrical nerve stimulation is also improved by modulating the frequency of the pulse rate variation.
Although the automatic control of pulse rate, pulse width, and pulse amplitude has been provided for in prior art systems, an automatic system combining these features with spatial variation of the stimulus situs has not. However, due to the wide variety of patient needs, a demand exists for such a system.
SUMMARY OF THE INVENTION
The present invention is an apparatus and method for producing patterned electrical tissue stimulation comprising a current generation means connected through a multiplexing means to a plurality of electrodes, the multiplexing means and the current means being connected to a control means, whereby electrical tissue stimulation is produced.
BRIEF DESCRIPTION OF THE DRAWING
In the drawing:
FIG. 1 is a block diagram of a Patterned Electrical Nerve Stimulator according to the present invention.
FIG. 2 is an illustration of possible electrode placement on a patient; and
FIGS. 3, 3a, 3b, and 3c are a flow chart of the software according to the present invention.
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENT
The invention as embodied in the block diagram of FIG. 1 comprises seven principal components: user interface 150, microprocessor 100, data latch 105, analog multiplexers 110 and 115, analog switch 120, and constant current source 125. In the embodiment, microcomputer 100 functions as the controller for elements 110, 115, and 120. While the embodiment shown in FIG. 1 utilizes an 1802 type microcomputer, any microcomputer or custom designed controller chip capable of performing the necessary functions may be substituted. User interface 150, which is connected to microprocessor 100 through multi-line connector 155, provides for on/off and stimulus intensity control.
Data latch 105 is connected to microcomputer 100 through data bus 103. It serves to store and synchronize output data from microcomputer 100 for control of analog multiplexers 110 and 115. Data buses 107 and 108 carry control data out of data latch 105 into analog multiplexers 110 and 115, respectively. Buses 107 and 108 each comprise four individual data lines which deliver multiplexing information to analog multiplexers 110 and 115.
Analog multiplexers 110 and 115 provide for a 1 to 16 multiplex. The parallel four bit codes applied through data buses 107 and 108 to the multiplexers 110 and 115 respectively, determine the multiplexing connections. Output lines 112 and 117 are connected through a suitable conductor arrangement 170 so that either input lines 111 or 116 to the respective analog multiplexers 110 and 115 may be connected to any of the 16 electrodes 200 (only eight are depicted) as shown in FIG. 2. While the embodiment shown in FIG. 1 features a dual 1 to 16 multiplexing system, it will be seen that minor modifications would provide for a lesser or greater multiplexing capability.
The inputs to analog multiplexers 110 and 115 are connected through conductors 113 and 118 to the respective outputs 114 and 119 of analog switch 120. Microprocessor Q line output 144 controls analog switch 120 so that outputs 114 and 119 may be connected to inputs 132 and 130, respectively, or 130 and 132, respectively. On/off control of analog switch 120 is provided for by line 148 to microprocessor 100. Inputs 132 and 130 are connected through conductors 140 and 138 to respective outputs 134 and 136 of constant current source 125. As illustrated, outputs 134 and 136 of constant current source 125 have the respective polarities of positive and negative. In the described configuration it will be seen that the polarity of outputs 114 and 119 toggle or alternate in response to signals input from Q line 144 to analog switch 120.
In the preferred embodiment, electrode array 200 comprises 16 independent transcutaneous electrodes each with an area on the order of 10 square millimeters. However, it will be seen that electrode array 200 may be comprised of subcutaneous electrodes. The electrodes comprising array 200 may be of any type generally known in the art, only reduced in size. Each electrode in the array has two connections, one to a corresponding output 112 of multiplexer 110 and the other to the corresponding output 117 of multiplexer 115. For example, electrode 235 would be connected to analog multiplexers 110 and 115 at each respective "1" output. This allows for any two electrodes in array 200 to be selected as a stimulus pair. The electrodes comprising electrode array 200, as shown in FIG. 2, may be secured to (or in) the patient's body to form any desirable arrangement. For example, the electrodes may be arranged in groups of four (210) or in a line (215). In any event, it is generally known in the art that a minimum spacing of approximately one to two inches is necessary in order for the patient to perceive a spatial separation of stimulus origin.
It is also generally known in the art that patients are unable to temporally distinguish between stimulation pulses effectuated within about 4 milliseconds of each other. In the preferred embodiment, this physiological limitation allows a single perceptible stimulation pulse to be produced with a sequential pulsing of two or more electrode pairs. The operation of the circuitry shown in FIG. 1 to create such an effect will be described in the following paragraphs.
For the purpose of illustration, imagine that the tissue below the perimeter defined by electrodes 235, 220, 225, and 230 (as shown in FIG. 2) is sought to be electrically stimulated. As will be explained later (in the software discussion), this task may be performed in the system's "immediate" mode. The four electrodes (i.e., 235, 220, 225, and 230) may be paired to form up to six independent combinations. As stated above, stimulation pulses delivered to any of the six possible pairs within a 4 millisecond period will be temporally indistinguishable to the patient. Due to circuit and technique limitations in the particular embodiment shown as hereinafter described, a maximum of four pairs of electrodes may be pulsed within any given 4 millisecond period. For this example, assume the four electrode pairs 235 and 230, 220 and 225, 220 and 230, and 235 and 225 will be sequentially pulsed so as to blend the four pulse bursts into a single perceived stimulation event.
Referring to FIG. 1, it will be seen that the first step in accomplishing the desired stimulation is connecting constant current source 125 outputs 134 and 136 to the first pair of electrodes 235 and 230, respectively. To do so, microprocessor 100 loads the proper multiplexing data into data latch 105 through data bus 103. This multiplex code is then conducted to multiplexers 110 and 115 through data buses 107 and 108, respectively, resulting in the connection of electrodes 235 and 230 to inputs 111 and 116. In the preferred embodiment, this sequence of events takes about 50 microseconds. Once the electrode pair has been connected, electrical tissue stimulation is produced by constant current source 125 and analog switch 120. Constant current source 125 produces a constant current of up to 5 milliamps between its outputs 134 and 136 given any reactance less than 2.5 kilohms. After enabling analog switch 120 through line 148, microprocessor Q line output 144 is used to toggle analog switch 120 so that bi-phasic pulses with a current amplitude of approximately 2-4 milliamps and a period of approximately 80 microseconds are delivered to the selected electrode pair. Although each individual bi-phasic pulse is marginally perceptible, a series of two or more produce an easily discernible effect. In the present example, approximately ten such pulses could be sequentially delivered to the electrode pair 235 and 213, consuming a total time interval of approximately 800 microseconds. It should be seen that while the toggling of electrode polarities could be accomplished by reversing the multiplexing connections, the additional time required to do so as compared with toggling analog switch 120 with Q line 144 makes it less desirable. While Q line 144 may be toggled with only a few instructions in the microprocessor, the reversal of multiplexing connections requires additional instructions and the further delay of data latch 105.
After delivering up to ten bi-phasic pulses to the first selected electrode pair, microprocessor 100 automatically connects the next pair. It will be seen that the total elapsed time between the connection of the first electrode pair, the subsequent pulsing, and the connection to the second electrode pair will be no more than 1 millisecond. In this manner, four distinct stimuli (pulse bursts) may be used to produce what is perceived by the patient as a single stimulation event or pulse. This technique provides a major advantage over the conventional two electrode system in that it can greatly enhance tissue current distribution without altering the patient's stimulus perception.
The microprocessor software most pertinent to the key operations of the present invention is flowcharted in FIG. 3. Initialize block 310 represents the functions performed by the microprocessor at the outset of each use. Initialize functions include, but are not limited to, such things as clearing data latches and presetting program counters. Flow chart box 320 represents the software code which retrieves stimulation instructions from memory chips such as EPROMS or ROMS. In the present embodiment these instructions are stored in two eight-bit words, one word containing the electrode pair choice and the other word frequency-duratin code. The frequency code controls the time between stimulation bursts (stimulation frequency), while the duration code controls the length of time between changes in the stimulation frequency. The stimulation frequency and its duration are both programmable. The former from 2 to 500 Hz and the latter from 500 milliseconds to 10 seconds. The software which decodes these eight-bit words into usable form is represented by box 325. Using a standard 4k ROM, it will be seen that up to 10 hours of continuously varying stimulation can be accomplished.
As previously described, user interface 150 includes two buttons for control of stimulus intensity. During the initialization process, microprocessor 100 presets the intensity control value to its minimum setting. Flow chart block 330 corresponds to the software which retrieves this intensity value from memory for use during the stimulation process. In the present embodiment, the intensity value controls the quantity of sequential bi-phasic pulses delivered during each pulse burst. Block 335 represents the software which places the intensity value retrieved from the memory into an intensity pulse counter. The compliment of this value is then loaded into the intensity pulse compensation counter (block 340). After these counters have been loaded, data latch 105 is loaded with the eight bits corresponding to the two selected electrodes (block 345). The software (indicated by block 350) then initiates the electrical nerve stimulation process by enabling analog switch 120.
Flow chart boxes 355-390 represent the software which produces bursts of bi-phasic pulses and the corresponding delays thereafter. Basically, a series of bi-phasic pulses is produced and then followed by a complementary delay period so as to maintain a uniform operational delay for all possible stimulation intensity levels. After each such burst is complete, the decoded frequency (decoded in box 325) is retrieved from the memory and analyzed by the software corresponding to box 400. This analysis reveals either a programmed delay or an "immediate" mode command. The "immediate" mode "if" statement in box 400 provides the means whereby the system can switch immediately to another electrode pair without a delay (e.g., as described in the illustrative example). If in the "immediate" mode the software relating to block 400 directs the microprocessor 100 to block 320, where the next segment of stimulation data is read from the memory.
When not in the "immediate" mode, the program advances to flow chart block 405, where the software represented thereby converts the frequency to an appropriate delay count. The software corresponding to block 410 interrogates the duration counter for decision in block 415. If the duration counter is equal to zero the program advances to block 420 where the duration code is converted to appropriate duration count. If the duration counter is not at zero, the program advances to software block 425, which comprises a software delay designed to simulate the delay introduced by block 420. From both blocks 420 and 425 the program advances to the software represented by blocks 430 through 450. The software represented by these blocks comprises the microprocessor 100 user interface 150 interrogation routine. This routine involves sensing the stimulation buttons on user interface 150. If either the increment or decrement button is currently depressed, the software will adjust the intensity value accordingly providing there have been no changes within the last three seconds (block 440). If neither button is depressed, the program will jump from block 430 to block 445. Program flow chart boxes 445 allow the pattern source to be altered during operation. For example, a patient may have several alternative patterns to choose from. These patterns may be in one master ROM or several smaller ones. Next, the program begins to loop through blocks 455 to 470. This routine provides for the delay from each stimulation burst to the next and for control of the duration of the stimulation frequency In the case where the duration period is incomplete, box 475 directs the program flow back to box 330 to reinitiate the process which begins therefrom. If the duration count is complete, box 475 directs the program flow to box 320 where new instructions are read from the memory and the stimulation process is reinitiated. While the foregoing program flow chart description describes in adequate detail the interaction and operation of the software of the present invention, it will be observed that other programs which adequately perform these and other tasks may be substituted.
It is readily seen that spatially modulated or patterned stimulation can be accomplished by changing the stimulating electrode pair or pairs every so often as necessary to produce a traveling stimulus sensation to the patient. In a similar manner, the frequency of stimulation may be varied automatically (by varying the duration code) so as to provide any known type of temporal variations (e.g., 1/f, rhythmic, random, or progressive). These spatial and temporal patterns are easily programmed into the memory media directly (e.g., using a PROM burner) or through any higher level software systems adapted for such use.
In the present invention, the capability to spatially and temporally modulate the electrical stimulus provides the means to overcome the problems normally associated with electrical nerve stimulation. For example, the habituation effects caused by excessive stimulation to any particular tissue situs or that induced by monotony of stimulation frequency and intensity. Furthermore, the present invention provides the means for ready adaptation of electrical stimulus technique so that a wide variety of patient needs may be satisfied. ##SPC1##

Claims (5)

What is claimed:
1. A portable automatically controlled electrical tissue stimulator comprising:
means for producing electrical stimulation current, the polarity of said current controllable by a current control signal;
a plurality of electrodes for attachment in an array to a patient to be treated;
multiplexing means operatively connected between said current means and said electrodes, and responsive to a multiplexing signal for selectively connecting any pair of electrodes to said current means; and
presettable automatic control means including memory means for storing presettable digitally encoded information indicative of a desired sequence of electrode pair connections and a desired number of current pulses to be applied to each of the pairs connected in the sequence and further including means responsive to said information stored in said memory means to produce said multiplexing signal and said current control signal to cause said electrodes to be sequentially connected to said current means automatically and stimulation current pulses of alternating polarity to be delivered to said pairs of said electrodes automatically.
2. An apparatus according to claim 2 wherein said presettable automatic control means comprises a microprocessor.
3. An apparatus according to claim 1, wherein said presettable automatic control means includes means for causing a plurality of electrode pairs to be connected in sequence to said means for producing electrical stimulation current, within a 4 msec period, so that the electrical stimulation delivered to each of said electrode pairs is temporarily indistinguishable to the patient.
4. An apparatus according to claim 1, wherein each of the current pulses produced by said means for producing said stimulation current are generated at an intensity level substantially equal to or less than the level of human perception.
5. An apparatus according to claim 4, wherein said presettable automatic control means includes means for causing a plurality of said current pulses to be delivered to a connected electrode pair within a duration of time short enough to cause said pulses to be temporarily summed in the stimulated tissue.
US06/259,099 1981-04-30 1981-04-30 Patterned electrical tissue stimulator Expired - Lifetime US4390023A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US06/259,099 US4390023A (en) 1981-04-30 1981-04-30 Patterned electrical tissue stimulator

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/259,099 US4390023A (en) 1981-04-30 1981-04-30 Patterned electrical tissue stimulator

Publications (1)

Publication Number Publication Date
US4390023A true US4390023A (en) 1983-06-28

Family

ID=22983532

Family Applications (1)

Application Number Title Priority Date Filing Date
US06/259,099 Expired - Lifetime US4390023A (en) 1981-04-30 1981-04-30 Patterned electrical tissue stimulator

Country Status (1)

Country Link
US (1) US4390023A (en)

Cited By (86)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985001214A1 (en) * 1983-09-16 1985-03-28 Webster Wilton W Jr Electrophysiological switching unit
US4524774A (en) * 1981-07-30 1985-06-25 Deutsche Nemectron Gmbh Apparatus and method for the stimulation of a human muscle
US4528984A (en) * 1983-04-25 1985-07-16 Empi, Inc. Autoprogrammable functional electrical stimulation apparatus and method
US4580569A (en) * 1983-12-15 1986-04-08 Wright State University Apparatus and method for muscle stimulation
US4592359A (en) * 1985-04-02 1986-06-03 The Board Of Trustees Of The Leland Stanford Junior University Multi-channel implantable neural stimulator
US4598713A (en) * 1982-06-29 1986-07-08 Deutsche Nemectron Gmbh Electrostimulation therapy device and method
US4622973A (en) * 1984-06-15 1986-11-18 Empi, Inc. Programmable functional electrical stimulation system
US4630615A (en) * 1984-05-21 1986-12-23 Cordis Corporation Apparatus for measuring impedance
EP0211822A2 (en) * 1985-07-31 1987-02-25 HEPAX Limited Electromedical apparatus for therapy
US4676257A (en) * 1984-12-20 1987-06-30 Pain Prevention, Inc. Dental anesthesia apparatus
US4688574A (en) * 1985-06-17 1987-08-25 Minnesota Mining And Manufacturing Company Electrical stimulator for biological tissue having mode control
US4690145A (en) * 1985-06-17 1987-09-01 Minnesota Mining And Manufacturing Company Output limited electrical stimulator for biological tissue
US4703755A (en) * 1984-05-18 1987-11-03 The Regents Of The University Of California Control system for the stimulation of two bodily functions
US4712558A (en) * 1984-03-13 1987-12-15 Bio Medical Research Ltd. Electrical stimulation of muscle
US4735204A (en) * 1984-09-17 1988-04-05 Cordis Corporation System for controlling an implanted neural stimulator
EP0268701A1 (en) * 1986-11-26 1988-06-01 JAMUTRON GERÄTEBAU GmbH Electric stimulator for medical and cosmetic applications
WO1988007392A1 (en) * 1987-03-26 1988-10-06 Intrinsic Ag Signal control process, electric treatment device and electrode system
US4793353A (en) * 1981-06-30 1988-12-27 Borkan William N Non-invasive multiprogrammable tissue stimulator and method
US4799487A (en) * 1987-05-11 1989-01-24 Bleicher Joel N Reanimation device and method for treating the paralyzed face
US4875484A (en) * 1986-10-04 1989-10-24 Total Human Medical Laboratory Co., Ltd. Method for generating a low frequency electric stimulus signal and low frequency electric stimulus signal generating apparatus
US4889111A (en) * 1984-02-08 1989-12-26 Ben Dov Meir Bone growth stimulator
USRE33420E (en) * 1984-09-17 1990-11-06 Cordis Corporation System for controlling an implanted neural stimulator
US5041974A (en) * 1988-10-26 1991-08-20 Walker Judith B Multichannel stimulator for tuned stimulation
US5069211A (en) * 1989-08-25 1991-12-03 Staodyn, Inc. Microprocessor controlled electronic stimulating device having biphasic pulse output
US5263481A (en) * 1992-05-21 1993-11-23 Jens Axelgaard Electrode system with disposable gel
US5281219A (en) * 1990-11-23 1994-01-25 Medtronic, Inc. Multiple stimulation electrodes
AT397768B (en) * 1992-07-02 1994-06-27 Hospitech Medizintechnik Ges M CURRENT FORM SYNTHESIS DEVICE FOR STREAM CURRENT THERAPY AND DIAGNOSTIC DEVICES OR THE LIKE.
US5755749A (en) * 1995-08-08 1998-05-26 Toyo Sangyo Co., Ltd. Change control method using three-dimensional 1/F fluctuation, recording medium storing the method, and change control device using three-dimensional 1/F fluctuation
US5891182A (en) * 1995-10-11 1999-04-06 Regeneration Tech Bio-active frequency generator and method
US5938690A (en) * 1996-06-07 1999-08-17 Advanced Neuromodulation Systems, Inc. Pain management system and method
WO2000043064A1 (en) * 1999-01-25 2000-07-27 Esd Limited Liability Company Method and apparatus for treating oropharyngeal, respiratory and oral motor neuromuscular disorders with electrical stimulation
US6516227B1 (en) 1999-07-27 2003-02-04 Advanced Bionics Corporation Rechargeable spinal cord stimulator system
GB2378903A (en) * 2001-07-12 2003-02-26 Bmr Res & Dev Ltd Electrical tissue and nerve stimulation with spacial and temporal discrimination by switching of arrayed electrodes.
US6564079B1 (en) 2000-07-27 2003-05-13 Ckm Diagnostics, Inc. Electrode array and skin attachment system for noninvasive nerve location and imaging device
WO2003059441A1 (en) * 2002-01-11 2003-07-24 Medtronic, Inc. Variation of neural-stimulation parameters
US6609031B1 (en) 1996-06-07 2003-08-19 Advanced Neuromodulation Systems, Inc. Multiprogrammable tissue stimulator and method
US20030204232A1 (en) * 2002-04-30 2003-10-30 Sommer John L. Method and apparatus for selecting an optimal electrode configuration of a medical electrical lead having a multiple electrode array
US6725086B2 (en) 2001-01-17 2004-04-20 Draeger Medical Systems, Inc. Method and system for monitoring sedation, paralysis and neural-integrity
US20040147978A1 (en) * 2002-12-12 2004-07-29 Bernhard Axel L. Electro stimulation treatment apparatus and method
US20040176831A1 (en) * 2000-07-13 2004-09-09 Gliner Bradford Evan Apparatuses and systems for applying electrical stimulation to a patient
US20040210274A1 (en) * 2000-04-27 2004-10-21 Medtronic, Inc. Patient directed therapy management
US20040249422A1 (en) * 2002-12-10 2004-12-09 Gliner Bradford Evan Systems and methods for enhancing or optimizing neural stimulation therapy for treating symptoms of movement disorders and/or other neurologic dysfunction
US20040267328A1 (en) * 2003-06-24 2004-12-30 Medtronic, Inc. Electrode selection system for medical electrical leads
US20050021105A1 (en) * 2000-07-13 2005-01-27 Firlik Andrew D. Methods and apparatus for effectuating a change in a neural-function of a patient
US20050116742A1 (en) * 2003-11-27 2005-06-02 Wen-Lin Liang Non-fixed oscillatory wave signal generating method and apparatus
US20050149145A1 (en) * 2003-12-29 2005-07-07 Coulter George G. Enhanced device for diminishing or eliminating the pain caused by superficial therapeutic injection or superficial body tissue sampling or the pain from a superficial injury as well as for the reduction of hemorrhage from an injured area
US20050228451A1 (en) * 1998-07-06 2005-10-13 Jaax Kristen N Methods and systems for treating chronic pelvic pain
US20060030906A1 (en) * 2004-08-06 2006-02-09 Carroll William J Switchable and programmable electrode configuration
US20060106430A1 (en) * 2004-11-12 2006-05-18 Brad Fowler Electrode configurations for reducing invasiveness and/or enhancing neural stimulation efficacy, and associated methods
US7066910B2 (en) 2000-04-27 2006-06-27 Medtronic, Inc. Patient directed therapy management
US20060217768A1 (en) * 2005-01-28 2006-09-28 Felix Buhlmann Independent protection system for an electrical muscle stimulation apparatus and method of using same
US20060253171A1 (en) * 2004-11-12 2006-11-09 Northstar Neuroscience, Inc. Systems and methods for selecting stimulation sites and applying treatment, including treatment of symptoms of parkinson's disease, other movement disorders, and/or drug side effects
US20070032834A1 (en) * 2000-07-13 2007-02-08 Northstar Neuroscience, Inc. Systems and methods for automatically optimizing stimulus parameters and electrode configurations for neuro-stimulators
US7177696B1 (en) 1999-06-09 2007-02-13 H & P Medical Research, Inc. Multiple selectable field/current-voltage pads having individually powered and controlled cells
EP1786510A2 (en) * 2004-07-15 2007-05-23 Northstar Neuroscience, Inc. Systems and methods for enhancing or affecting neural stimulation efficiency and/or efficacy
WO2007035849A3 (en) * 2005-09-21 2007-10-11 Univ Ohio State Electrical stimulation of cell and tissue growth with two-and-three-dimensionally patterned electrodes
US20070293914A1 (en) * 1999-07-27 2007-12-20 Advanced Bionics Corporation Patient programmer for implantable devices
US20070293911A1 (en) * 2001-01-16 2007-12-20 B.M.R. Research And Development, Ltd. Apparatus for stimulating a muscle of a subject
US20080046052A1 (en) * 2006-04-28 2008-02-21 Medtronic, Inc. Method and apparatus providing asynchronous neural stimulation
US20080103559A1 (en) * 2006-10-26 2008-05-01 Advanced Bionics Corporation Method of maintaining intensity output while adjusting pulse width or amplitude
US20090018611A1 (en) * 2007-07-11 2009-01-15 Campbell Russell A Method and apparatus for laryngeal elevator musculature rehabilitation
US20090054947A1 (en) * 2007-08-20 2009-02-26 Medtronic, Inc. Electrode configurations for directional leads
US20090054955A1 (en) * 2007-08-20 2009-02-26 Kopell Brian H Systems and Methods for Treating Neurological Disorders by Light Stimulation
US7565199B2 (en) 2002-12-09 2009-07-21 Advanced Neuromodulation Systems, Inc. Methods for treating and/or collecting information regarding neurological disorders, including language disorders
AU2003294151B2 (en) * 2002-12-12 2009-07-23 Skop Gmbh Ltd Electro stimulation treatment apparatus and method
US20100004715A1 (en) * 2008-07-02 2010-01-07 Brian Fahey Systems and methods for automated muscle stimulation
US20100042180A1 (en) * 2005-04-19 2010-02-18 Compex Technologies, Inc Electrical stimulation device and method for therapeutic treatment and pain management
US20100057149A1 (en) * 2008-08-26 2010-03-04 Brian Fahey Device, system, and method to improve powered muscle stimulation performance in the presence of tissue edema
US7684866B2 (en) 2003-08-01 2010-03-23 Advanced Neuromodulation Systems, Inc. Apparatus and methods for applying neural stimulation to a patient
US7756584B2 (en) 2000-07-13 2010-07-13 Advanced Neuromodulation Systems, Inc. Methods and apparatus for effectuating a lasting change in a neural-function of a patient
US20100217349A1 (en) * 2009-02-20 2010-08-26 Fahey Brian J Systems and Methods of Powered Muscle Stimulation Using an Energy Guidance Field
US7831305B2 (en) 2001-10-15 2010-11-09 Advanced Neuromodulation Systems, Inc. Neural stimulation system and method responsive to collateral neural activity
US20110112605A1 (en) * 2009-11-11 2011-05-12 Fahey Brian J Synergistic Muscle Activation Device
US8295943B2 (en) 2007-08-20 2012-10-23 Medtronic, Inc. Implantable medical lead with biased electrode
US8326418B2 (en) 2007-08-20 2012-12-04 Medtronic, Inc. Evaluating therapeutic stimulation electrode configurations based on physiological responses
US8583240B2 (en) 2011-07-18 2013-11-12 Marcy L. Freed Device and method for treating dysphagia with electrical stimulation
US8620438B1 (en) 2007-02-13 2013-12-31 Encore Medical Asset Corporation Method and apparatus for applying neuromuscular electrical stimulation
US20140236176A1 (en) * 2013-02-15 2014-08-21 Ranu Jung Method for mapping sensor signals to output channels for neural activation
US8892210B2 (en) 2008-07-02 2014-11-18 Niveus Medical, Inc. Devices, systems, and methods for automated optimization of energy delivery
US9101768B2 (en) 2013-03-15 2015-08-11 Globus Medical, Inc. Spinal cord stimulator system
US9149386B2 (en) 2008-08-19 2015-10-06 Niveus Medical, Inc. Devices and systems for stimulation of tissues
US9149635B2 (en) 2012-04-27 2015-10-06 Medtronic, Inc. Stimulation waveform generator for an implantable medical device
US9872997B2 (en) 2013-03-15 2018-01-23 Globus Medical, Inc. Spinal cord stimulator system
US9878170B2 (en) 2013-03-15 2018-01-30 Globus Medical, Inc. Spinal cord stimulator system
US9887574B2 (en) 2013-03-15 2018-02-06 Globus Medical, Inc. Spinal cord stimulator system
WO2019126080A1 (en) * 2017-12-18 2019-06-27 Dan Sachs Devices, systems and methods for therapeutic muscle stimulation

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2864371A (en) * 1954-06-14 1958-12-16 Casther S A Device for the control of electrical supply for electrotherapeutic purposes, especially for stimulotherapy
US3814106A (en) * 1972-04-14 1974-06-04 American Optical Corp Atrial and ventricular pacer having independent rate controls and means to maintain a constant av delay
US3902502A (en) * 1974-09-13 1975-09-02 Saul Liss Apparatus for temporarily arresting arthritic pain
US4066086A (en) * 1975-06-05 1978-01-03 Medtronic, Inc. Programmable body stimulator
US4192316A (en) * 1978-05-22 1980-03-11 Arco Medical Products Company Programmable atrio-ventricular pacer
US4227516A (en) * 1978-12-13 1980-10-14 Meland Bruce C Apparatus for electrophysiological stimulation
US4237899A (en) * 1978-09-26 1980-12-09 Stimtech, Inc. Electronic tissue stimulator with output signal controls
US4324253A (en) * 1977-01-28 1982-04-13 Greene Ronald W Transcutaneous pain control and/or muscle stimulating apparatus

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2864371A (en) * 1954-06-14 1958-12-16 Casther S A Device for the control of electrical supply for electrotherapeutic purposes, especially for stimulotherapy
US3814106A (en) * 1972-04-14 1974-06-04 American Optical Corp Atrial and ventricular pacer having independent rate controls and means to maintain a constant av delay
US3902502A (en) * 1974-09-13 1975-09-02 Saul Liss Apparatus for temporarily arresting arthritic pain
US4066086A (en) * 1975-06-05 1978-01-03 Medtronic, Inc. Programmable body stimulator
US4066086B1 (en) * 1975-06-05 1984-06-05
US4324253A (en) * 1977-01-28 1982-04-13 Greene Ronald W Transcutaneous pain control and/or muscle stimulating apparatus
US4192316A (en) * 1978-05-22 1980-03-11 Arco Medical Products Company Programmable atrio-ventricular pacer
US4237899A (en) * 1978-09-26 1980-12-09 Stimtech, Inc. Electronic tissue stimulator with output signal controls
US4227516A (en) * 1978-12-13 1980-10-14 Meland Bruce C Apparatus for electrophysiological stimulation

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
"A Serial to Parallel Interface System for Tens Pain Suppression", Petrucelli et al. *
"Conference on Cutaneous Communication Systems and Devices", Saunders, 1973. *
"Electrical Stimulation of Pain and Touch", R. H. Gibson. *
"Pain Control by Transcutaneous Electrical Nerve Stimulating Using Irregular Pulse of l/f Fluctuation", Kintoma Takakura et al, Applied Neurophysiology, vol. 42, 1979, pp. 314-315. *
"The Empi Tens System", Advertisement, Empi, Inc., 1981. *
"Theoretical Design and Implementation of a Transcutaneous, Multichannel Stimulator For Neural Prosthesis Applications", Ian C. Forster, 3/80. *
David I. Aidley, The Physiology of Excitable Cells, 2nd Edition Cambridge Univ. Press, .COPYRGT.1978, pp. 153-155. *
David I. Aidley, The Physiology of Excitable Cells, 2nd Edition Cambridge Univ. Press, ©1978, pp. 153-155.

Cited By (178)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4793353A (en) * 1981-06-30 1988-12-27 Borkan William N Non-invasive multiprogrammable tissue stimulator and method
US4524774A (en) * 1981-07-30 1985-06-25 Deutsche Nemectron Gmbh Apparatus and method for the stimulation of a human muscle
US4598713A (en) * 1982-06-29 1986-07-08 Deutsche Nemectron Gmbh Electrostimulation therapy device and method
US4528984A (en) * 1983-04-25 1985-07-16 Empi, Inc. Autoprogrammable functional electrical stimulation apparatus and method
US4554928A (en) * 1983-09-16 1985-11-26 Webster Wilton W Jr Electrophysiological switching unit
WO1985001214A1 (en) * 1983-09-16 1985-03-28 Webster Wilton W Jr Electrophysiological switching unit
US4580569A (en) * 1983-12-15 1986-04-08 Wright State University Apparatus and method for muscle stimulation
US4889111A (en) * 1984-02-08 1989-12-26 Ben Dov Meir Bone growth stimulator
US4712558A (en) * 1984-03-13 1987-12-15 Bio Medical Research Ltd. Electrical stimulation of muscle
US4703755A (en) * 1984-05-18 1987-11-03 The Regents Of The University Of California Control system for the stimulation of two bodily functions
US4630615A (en) * 1984-05-21 1986-12-23 Cordis Corporation Apparatus for measuring impedance
US4622973A (en) * 1984-06-15 1986-11-18 Empi, Inc. Programmable functional electrical stimulation system
USRE33420E (en) * 1984-09-17 1990-11-06 Cordis Corporation System for controlling an implanted neural stimulator
US4735204A (en) * 1984-09-17 1988-04-05 Cordis Corporation System for controlling an implanted neural stimulator
US4676257A (en) * 1984-12-20 1987-06-30 Pain Prevention, Inc. Dental anesthesia apparatus
EP0198618A2 (en) * 1985-04-02 1986-10-22 The Board Of Trustees Of The Leland Stanford Junior University A mult-channel implantable neural stimulator
EP0198618A3 (en) * 1985-04-02 1988-08-10 The Board Of Trustees Of The Leland Stanford Junior University A mult-channel implantable neural stimulator
US4592359A (en) * 1985-04-02 1986-06-03 The Board Of Trustees Of The Leland Stanford Junior University Multi-channel implantable neural stimulator
US4688574A (en) * 1985-06-17 1987-08-25 Minnesota Mining And Manufacturing Company Electrical stimulator for biological tissue having mode control
US4690145A (en) * 1985-06-17 1987-09-01 Minnesota Mining And Manufacturing Company Output limited electrical stimulator for biological tissue
AT385664B (en) * 1985-07-31 1988-05-10 Hepax Ltd ELECTROMEDICAL THERAPY DEVICE
EP0211822A3 (en) * 1985-07-31 1988-05-11 HEPAX Limited Electromedical apparatus for therapy
EP0211822A2 (en) * 1985-07-31 1987-02-25 HEPAX Limited Electromedical apparatus for therapy
US4875484A (en) * 1986-10-04 1989-10-24 Total Human Medical Laboratory Co., Ltd. Method for generating a low frequency electric stimulus signal and low frequency electric stimulus signal generating apparatus
EP0268701A1 (en) * 1986-11-26 1988-06-01 JAMUTRON GERÄTEBAU GmbH Electric stimulator for medical and cosmetic applications
WO1988007392A1 (en) * 1987-03-26 1988-10-06 Intrinsic Ag Signal control process, electric treatment device and electrode system
US4799487A (en) * 1987-05-11 1989-01-24 Bleicher Joel N Reanimation device and method for treating the paralyzed face
US5041974A (en) * 1988-10-26 1991-08-20 Walker Judith B Multichannel stimulator for tuned stimulation
US5069211A (en) * 1989-08-25 1991-12-03 Staodyn, Inc. Microprocessor controlled electronic stimulating device having biphasic pulse output
US5281219A (en) * 1990-11-23 1994-01-25 Medtronic, Inc. Multiple stimulation electrodes
US5263481A (en) * 1992-05-21 1993-11-23 Jens Axelgaard Electrode system with disposable gel
AT397768B (en) * 1992-07-02 1994-06-27 Hospitech Medizintechnik Ges M CURRENT FORM SYNTHESIS DEVICE FOR STREAM CURRENT THERAPY AND DIAGNOSTIC DEVICES OR THE LIKE.
US5755749A (en) * 1995-08-08 1998-05-26 Toyo Sangyo Co., Ltd. Change control method using three-dimensional 1/F fluctuation, recording medium storing the method, and change control device using three-dimensional 1/F fluctuation
US5891182A (en) * 1995-10-11 1999-04-06 Regeneration Tech Bio-active frequency generator and method
US6198970B1 (en) 1995-10-27 2001-03-06 Esd Limited Liability Company Method and apparatus for treating oropharyngeal respiratory and oral motor neuromuscular disorders with electrical stimulation
US5938690A (en) * 1996-06-07 1999-08-17 Advanced Neuromodulation Systems, Inc. Pain management system and method
US20050090876A1 (en) * 1996-06-07 2005-04-28 Jay Law Multiprogrammable tissue stimulator and method
US7254445B2 (en) 1996-06-07 2007-08-07 Advanced Neuromodulation Systems, Inc. Multiprogrammable tissue stimulator and method
US7127297B2 (en) 1996-06-07 2006-10-24 Advanced Neuromodulation Systems, Inc. Multiprogrammable tissue stimulator and method
US6609031B1 (en) 1996-06-07 2003-08-19 Advanced Neuromodulation Systems, Inc. Multiprogrammable tissue stimulator and method
US7890176B2 (en) 1998-07-06 2011-02-15 Boston Scientific Neuromodulation Corporation Methods and systems for treating chronic pelvic pain
US20050228451A1 (en) * 1998-07-06 2005-10-13 Jaax Kristen N Methods and systems for treating chronic pelvic pain
WO2000043064A1 (en) * 1999-01-25 2000-07-27 Esd Limited Liability Company Method and apparatus for treating oropharyngeal, respiratory and oral motor neuromuscular disorders with electrical stimulation
US20070150035A1 (en) * 1999-06-09 2007-06-28 Kiril Pandelisev Multiple Selectable Field/Current-Voltage Pads Having Individually Powered and Controlled Cells
US7177696B1 (en) 1999-06-09 2007-02-13 H & P Medical Research, Inc. Multiple selectable field/current-voltage pads having individually powered and controlled cells
US6895280B2 (en) 1999-07-27 2005-05-17 Advanced Bionics Corporation Rechargeable spinal cord stimulator system
US6516227B1 (en) 1999-07-27 2003-02-04 Advanced Bionics Corporation Rechargeable spinal cord stimulator system
US8918174B2 (en) 1999-07-27 2014-12-23 Boston Scientific Neuromodulation Corporation Patient programmer for implantable devices
US7496404B2 (en) 1999-07-27 2009-02-24 Boston Scientific Neuromodulation Corporation Rechargeable spinal cord stimulator system
US7769462B2 (en) 1999-07-27 2010-08-03 Boston Scientific Neuromodulation Corporation Rechargeable spinal cord stimulation system
US9907957B2 (en) 1999-07-27 2018-03-06 Boston Scientific Neuromodulation Corporation Patient programmer for implantable devices
US20070293914A1 (en) * 1999-07-27 2007-12-20 Advanced Bionics Corporation Patient programmer for implantable devices
US20070276450A1 (en) * 1999-07-27 2007-11-29 Advanced Bionics Corporation Rechargeable spinal cord stimulation system
US7801615B2 (en) 1999-07-27 2010-09-21 Boston Scientific Neuromodulation Corporation Rechargeable spinal cord stimulator system
US20040210274A1 (en) * 2000-04-27 2004-10-21 Medtronic, Inc. Patient directed therapy management
US7082333B1 (en) 2000-04-27 2006-07-25 Medtronic, Inc. Patient directed therapy management
US7066910B2 (en) 2000-04-27 2006-06-27 Medtronic, Inc. Patient directed therapy management
US8195300B2 (en) 2000-07-13 2012-06-05 Advanced Neuromodulation Systems, Inc. Systems and methods for automatically optimizing stimulus parameters and electrode configurations for neuro-stimulators
US20040176831A1 (en) * 2000-07-13 2004-09-09 Gliner Bradford Evan Apparatuses and systems for applying electrical stimulation to a patient
US7756584B2 (en) 2000-07-13 2010-07-13 Advanced Neuromodulation Systems, Inc. Methods and apparatus for effectuating a lasting change in a neural-function of a patient
US8412335B2 (en) 2000-07-13 2013-04-02 Advanced Neuromodulation Systems, Inc. Systems and methods for automatically optimizing stimulus parameters and electrode configurations for neuro-stimulators
US20050021105A1 (en) * 2000-07-13 2005-01-27 Firlik Andrew D. Methods and apparatus for effectuating a change in a neural-function of a patient
US8073546B2 (en) 2000-07-13 2011-12-06 Advanced Neuromodulation Systems, Inc. Methods and apparatus for effectuating a lasting change in a neural-function of a patient
US20070032834A1 (en) * 2000-07-13 2007-02-08 Northstar Neuroscience, Inc. Systems and methods for automatically optimizing stimulus parameters and electrode configurations for neuro-stimulators
US6564079B1 (en) 2000-07-27 2003-05-13 Ckm Diagnostics, Inc. Electrode array and skin attachment system for noninvasive nerve location and imaging device
US6609018B2 (en) 2000-07-27 2003-08-19 Ckm Diagnostics, Inc. Electrode array and sensor attachment system for noninvasive nerve location and imaging device
EP2263743A1 (en) * 2001-01-16 2010-12-22 BMR Research & Development Limited Apparatus for stimulating a muscle of a subject
US20070293911A1 (en) * 2001-01-16 2007-12-20 B.M.R. Research And Development, Ltd. Apparatus for stimulating a muscle of a subject
US6725086B2 (en) 2001-01-17 2004-04-20 Draeger Medical Systems, Inc. Method and system for monitoring sedation, paralysis and neural-integrity
EP2269690A1 (en) * 2001-07-12 2011-01-05 BMR Research & Development Limited Apparatus for electrical stimulation
US6944503B2 (en) 2001-07-12 2005-09-13 Bmr Research And Development Limited Method and apparatus for electrical stimulation
GB2378903A (en) * 2001-07-12 2003-02-26 Bmr Res & Dev Ltd Electrical tissue and nerve stimulation with spacial and temporal discrimination by switching of arrayed electrodes.
US20030093133A1 (en) * 2001-07-12 2003-05-15 Crowe Louis Michael Method and apparatus for electrical stimulation
US7831305B2 (en) 2001-10-15 2010-11-09 Advanced Neuromodulation Systems, Inc. Neural stimulation system and method responsive to collateral neural activity
US7873418B2 (en) 2002-01-11 2011-01-18 Medtronic, Inc. Variation of neural stimulation parameters
US9724514B2 (en) 2002-01-11 2017-08-08 Medtronic, Inc. Variation of neural stimulation parameters
US7050856B2 (en) 2002-01-11 2006-05-23 Medtronic, Inc. Variation of neural-stimulation parameters
WO2003059441A1 (en) * 2002-01-11 2003-07-24 Medtronic, Inc. Variation of neural-stimulation parameters
WO2003092807A1 (en) * 2002-04-30 2003-11-13 Medtronic, Inc. Method and apparatus for selecting an optimal electrode configuration
US6978178B2 (en) 2002-04-30 2005-12-20 Medtronic, Inc. Method and apparatus for selecting an optimal electrode configuration of a medical electrical lead having a multiple electrode array
US20030204232A1 (en) * 2002-04-30 2003-10-30 Sommer John L. Method and apparatus for selecting an optimal electrode configuration of a medical electrical lead having a multiple electrode array
US7565199B2 (en) 2002-12-09 2009-07-21 Advanced Neuromodulation Systems, Inc. Methods for treating and/or collecting information regarding neurological disorders, including language disorders
US7353064B2 (en) 2002-12-10 2008-04-01 Northstar Neuroscience, Inc. Systems and methods for enhancing or optimizing neural stimulation therapy for treating symptoms of movement disorders and/or other neurologic dysfunction
US20040249422A1 (en) * 2002-12-10 2004-12-09 Gliner Bradford Evan Systems and methods for enhancing or optimizing neural stimulation therapy for treating symptoms of movement disorders and/or other neurologic dysfunction
US9572978B2 (en) * 2002-12-12 2017-02-21 Skop Gmbh Ltd Electro stimulation treatment apparatus and method
US20040147978A1 (en) * 2002-12-12 2004-07-29 Bernhard Axel L. Electro stimulation treatment apparatus and method
AU2003294151B2 (en) * 2002-12-12 2009-07-23 Skop Gmbh Ltd Electro stimulation treatment apparatus and method
US20130066388A1 (en) * 2002-12-12 2013-03-14 Skop Gmbh Ltd Electro stimulation treatment apparatus and method
US20040267328A1 (en) * 2003-06-24 2004-12-30 Medtronic, Inc. Electrode selection system for medical electrical leads
US7684866B2 (en) 2003-08-01 2010-03-23 Advanced Neuromodulation Systems, Inc. Apparatus and methods for applying neural stimulation to a patient
US20050116742A1 (en) * 2003-11-27 2005-06-02 Wen-Lin Liang Non-fixed oscillatory wave signal generating method and apparatus
EP1699522A4 (en) * 2003-12-29 2008-02-27 Cliniwave Inc Apparatus for diminishing pain and/or hemorrhage caused by a therapeutic injection, body tissue sampling or injury
US20050165459A1 (en) * 2003-12-29 2005-07-28 Coulter George G. Apparatus for diminishing pain and/or hemorrhage caused by a therapeutic injection, body tissue sampling or injury
EP1699522A1 (en) * 2003-12-29 2006-09-13 CliniWave, Inc. Apparatus for diminishing pain and/or hemorrhage caused by a therapeutic injection, body tissue sampling or injury
US20050149145A1 (en) * 2003-12-29 2005-07-07 Coulter George G. Enhanced device for diminishing or eliminating the pain caused by superficial therapeutic injection or superficial body tissue sampling or the pain from a superficial injury as well as for the reduction of hemorrhage from an injured area
EP1786510A4 (en) * 2004-07-15 2009-12-02 Northstar Neuroscience Inc Systems and methods for enhancing or affecting neural stimulation efficiency and/or efficacy
EP1786510A2 (en) * 2004-07-15 2007-05-23 Northstar Neuroscience, Inc. Systems and methods for enhancing or affecting neural stimulation efficiency and/or efficacy
US7983762B2 (en) 2004-07-15 2011-07-19 Advanced Neuromodulation Systems, Inc. Systems and methods for enhancing or affecting neural stimulation efficiency and/or efficacy
US7483747B2 (en) 2004-07-15 2009-01-27 Northstar Neuroscience, Inc. Systems and methods for enhancing or affecting neural stimulation efficiency and/or efficacy
US8606361B2 (en) 2004-07-15 2013-12-10 Advanced Neuromodulation Systems, Inc. Systems and methods for enhancing or affecting neural stimulation efficiency and/or efficacy
US11786729B2 (en) 2004-07-15 2023-10-17 Advanced Neuromodulation Systems, Inc. Systems and methods for enhancing or affecting neural stimulation efficiency and/or efficacy
US20060030906A1 (en) * 2004-08-06 2006-02-09 Carroll William J Switchable and programmable electrode configuration
US7437196B2 (en) 2004-11-12 2008-10-14 Northstar Neuroscience, Inc. Systems and methods for selecting stimulation sites and applying treatment, including treatment of symptoms of Parkinson's disease, other movement disorders, and/or drug side effects
US20060253171A1 (en) * 2004-11-12 2006-11-09 Northstar Neuroscience, Inc. Systems and methods for selecting stimulation sites and applying treatment, including treatment of symptoms of parkinson's disease, other movement disorders, and/or drug side effects
US20060106430A1 (en) * 2004-11-12 2006-05-18 Brad Fowler Electrode configurations for reducing invasiveness and/or enhancing neural stimulation efficacy, and associated methods
US7565200B2 (en) * 2004-11-12 2009-07-21 Advanced Neuromodulation Systems, Inc. Systems and methods for selecting stimulation sites and applying treatment, including treatment of symptoms of Parkinson's disease, other movement disorders, and/or drug side effects
US20060217768A1 (en) * 2005-01-28 2006-09-28 Felix Buhlmann Independent protection system for an electrical muscle stimulation apparatus and method of using same
US8140165B2 (en) 2005-01-28 2012-03-20 Encore Medical Asset Corporation Independent protection system for an electrical muscle stimulation apparatus and method of using same
US9808619B2 (en) 2005-01-28 2017-11-07 Encore Medical Asset Corporation Independent protection system for an electrical muscle stimulation apparatus and method of using same
US8958883B2 (en) 2005-04-19 2015-02-17 Pierre-Yves Mueller Electrical stimulation device and method for therapeutic treatment and pain management
US20100042180A1 (en) * 2005-04-19 2010-02-18 Compex Technologies, Inc Electrical stimulation device and method for therapeutic treatment and pain management
US10328260B2 (en) 2005-04-19 2019-06-25 Djo, Llc Electrical stimulation device and method for therapeutic treatment and pain management
US9669212B2 (en) 2005-04-19 2017-06-06 Djo, Llc Electrical stimulation device and method for therapeutic treatment and pain management
US8478422B2 (en) * 2005-09-21 2013-07-02 The Ohio State University Electrical stimulation of cell and tissue growth with two-and three-dimensionally patterned electrodes
WO2007035849A3 (en) * 2005-09-21 2007-10-11 Univ Ohio State Electrical stimulation of cell and tissue growth with two-and-three-dimensionally patterned electrodes
US20100160999A1 (en) * 2005-09-21 2010-06-24 Arthur J Epstein Electrical Stimulation of Cell and Tissue Growth with Two-and Three-Dimensionally Patterned Electrodes
US8355789B2 (en) 2006-04-28 2013-01-15 Medtronic, Inc. Method and apparatus providing asynchronous neural stimulation
US20080046052A1 (en) * 2006-04-28 2008-02-21 Medtronic, Inc. Method and apparatus providing asynchronous neural stimulation
US20080103559A1 (en) * 2006-10-26 2008-05-01 Advanced Bionics Corporation Method of maintaining intensity output while adjusting pulse width or amplitude
US10456585B2 (en) 2006-10-26 2019-10-29 Boston Scientific Neuromodulation Corporation System and method to automatically maintain electrical stimulation intensity
US9943694B2 (en) 2006-10-26 2018-04-17 Boston Scientific Neuromodulation Corporation System and method to automatically maintain electrical stimulation intensity
US9352161B2 (en) 2006-10-26 2016-05-31 Boston Scientific Neuromodulation Corporation Method of maintaining intensity output while adjusting pulse width or amplitude
US11439831B2 (en) 2006-10-26 2022-09-13 Boston Scientific Neuromodulation Corporation Automatic adjustment to maintain evoked potential feature
US9352151B2 (en) 2007-02-13 2016-05-31 Encore Medical Asset Corporation Method and apparatus for applying neuromuscular electrical stimulation
US9669211B2 (en) 2007-02-13 2017-06-06 Encore Medical Asset Corporation Method and apparatus for applying neuromuscular electrical stimulation
US8620438B1 (en) 2007-02-13 2013-12-31 Encore Medical Asset Corporation Method and apparatus for applying neuromuscular electrical stimulation
US20090018611A1 (en) * 2007-07-11 2009-01-15 Campbell Russell A Method and apparatus for laryngeal elevator musculature rehabilitation
US20110190848A1 (en) * 2007-07-11 2011-08-04 Campbell Russell A Method and Apparatus for Laryngeal Elevator Musculature Rehabilitation
US9031659B2 (en) 2007-07-11 2015-05-12 Ampcare, Llc Method and apparatus for laryngeal elevator musculature rehabilitation
US7885713B2 (en) 2007-07-11 2011-02-08 Ampcare, Llc Method and apparatus for laryngeal elevator musculature rehabilitation
US8295943B2 (en) 2007-08-20 2012-10-23 Medtronic, Inc. Implantable medical lead with biased electrode
US8630719B2 (en) 2007-08-20 2014-01-14 Medtronic, Inc. Implantable medical lead with biased electrode
US20090054947A1 (en) * 2007-08-20 2009-02-26 Medtronic, Inc. Electrode configurations for directional leads
US20090054955A1 (en) * 2007-08-20 2009-02-26 Kopell Brian H Systems and Methods for Treating Neurological Disorders by Light Stimulation
US8538523B2 (en) 2007-08-20 2013-09-17 Medtronic, Inc. Evaluating therapeutic stimulation electrode configurations based on physiological responses
US8326418B2 (en) 2007-08-20 2012-12-04 Medtronic, Inc. Evaluating therapeutic stimulation electrode configurations based on physiological responses
US20100004715A1 (en) * 2008-07-02 2010-01-07 Brian Fahey Systems and methods for automated muscle stimulation
US8285381B2 (en) 2008-07-02 2012-10-09 Niveus Medical, Inc. Systems and methods for automated muscle stimulation
US10293152B2 (en) 2008-07-02 2019-05-21 Sage Products, Llc Devices, systems, and methods for automated optimization of energy delivery
US9302104B2 (en) 2008-07-02 2016-04-05 Niveus Medical, Inc. Devices, systems, and methods for automated optimization of energy delivery
US10987510B2 (en) 2008-07-02 2021-04-27 Sage Products, Llc Systems and methods for automated muscle stimulation
US8892210B2 (en) 2008-07-02 2014-11-18 Niveus Medical, Inc. Devices, systems, and methods for automated optimization of energy delivery
US9532899B2 (en) 2008-08-19 2017-01-03 Niveus Medical, Inc. Devices and systems for stimulation of tissue
US9149386B2 (en) 2008-08-19 2015-10-06 Niveus Medical, Inc. Devices and systems for stimulation of tissues
US20100057149A1 (en) * 2008-08-26 2010-03-04 Brian Fahey Device, system, and method to improve powered muscle stimulation performance in the presence of tissue edema
US8265763B2 (en) 2008-08-26 2012-09-11 Niveus Medical, Inc. Device, system, and method to improve powered muscle stimulation performance in the presence of tissue edema
US8676332B2 (en) 2009-02-20 2014-03-18 Niveus Medical, Inc. Systems and methods of powered muscle stimulation using an energy guidance field
US8433403B2 (en) 2009-02-20 2013-04-30 Niveus Medical, Inc. Systems and methods of powered muscle stimulation using an energy guidance field
US20100217349A1 (en) * 2009-02-20 2010-08-26 Fahey Brian J Systems and Methods of Powered Muscle Stimulation Using an Energy Guidance Field
US9126039B2 (en) 2009-11-11 2015-09-08 Niveus Medical, Inc. Synergistic muscle activation device
US8588901B2 (en) 2009-11-11 2013-11-19 Niveus Medical, Inc. Synergistic muscle activation device
US10478622B2 (en) 2009-11-11 2019-11-19 Sage Products, Llc Synergistic muscle activation device
US11839763B2 (en) 2009-11-11 2023-12-12 Sage Products, Llc Synergistic muscle activation device
US20110112605A1 (en) * 2009-11-11 2011-05-12 Fahey Brian J Synergistic Muscle Activation Device
US8583240B2 (en) 2011-07-18 2013-11-12 Marcy L. Freed Device and method for treating dysphagia with electrical stimulation
US9149635B2 (en) 2012-04-27 2015-10-06 Medtronic, Inc. Stimulation waveform generator for an implantable medical device
US20140236176A1 (en) * 2013-02-15 2014-08-21 Ranu Jung Method for mapping sensor signals to output channels for neural activation
US9440076B2 (en) 2013-03-15 2016-09-13 Globus Medical, Inc. Spinal cord stimulator system
US9872997B2 (en) 2013-03-15 2018-01-23 Globus Medical, Inc. Spinal cord stimulator system
US9956409B2 (en) 2013-03-15 2018-05-01 Globus Medical, Inc. Spinal cord stimulator system
US10016602B2 (en) 2013-03-15 2018-07-10 Globus Medical, Inc. Spinal cord stimulator system
US10016605B2 (en) 2013-03-15 2018-07-10 Globus Medical, Inc. Spinal cord stimulator system
US10149977B2 (en) 2013-03-15 2018-12-11 Cirtec Medical Corp. Spinal cord stimulator system
US10265526B2 (en) 2013-03-15 2019-04-23 Cirtec Medical Corp. Spinal cord stimulator system
US9878170B2 (en) 2013-03-15 2018-01-30 Globus Medical, Inc. Spinal cord stimulator system
US9872986B2 (en) 2013-03-15 2018-01-23 Globus Medical, Inc. Spinal cord stimulator system
US9101768B2 (en) 2013-03-15 2015-08-11 Globus Medical, Inc. Spinal cord stimulator system
US10335597B2 (en) 2013-03-15 2019-07-02 Cirtec Medical Corp. Spinal cord stimulator system
US9887574B2 (en) 2013-03-15 2018-02-06 Globus Medical, Inc. Spinal cord stimulator system
US9623246B2 (en) 2013-03-15 2017-04-18 Globus Medical, Inc. Spinal cord stimulator system
US10810614B2 (en) 2013-03-15 2020-10-20 Cirtec Medical Corp. Spinal cord stimulator system
US9550062B2 (en) 2013-03-15 2017-01-24 Globus Medical, Inc Spinal cord stimulator system
US9492665B2 (en) 2013-03-15 2016-11-15 Globus Medical, Inc. Spinal cord stimulator system
US9308369B2 (en) 2013-03-15 2016-04-12 Globus Medical, Inc. Spinal cord stimulator system
US11704688B2 (en) 2013-03-15 2023-07-18 Cirtec Medical Corp. Spinal cord stimulator system
US11478630B2 (en) 2017-12-18 2022-10-25 Dan Sachs Devices, systems and methods for therapeutic muscle stimulation
WO2019126080A1 (en) * 2017-12-18 2019-06-27 Dan Sachs Devices, systems and methods for therapeutic muscle stimulation
US11839757B2 (en) 2017-12-18 2023-12-12 Iambic Science, LLC Therapeutic muscle stimulation such as for lymphedema

Similar Documents

Publication Publication Date Title
US4390023A (en) Patterned electrical tissue stimulator
US4759368A (en) Transcutaneous nerve stimulator
US5964789A (en) Transcutaneous electric muscle/nerve controller/feedback unit
US4556064A (en) Electrotherapy acupuncture apparatus and method
AU696916B2 (en) A multichannel cochlear prosthesis with flexible control of stimulus waveforms
US4917092A (en) Transcutaneous nerve stimulator for treatment of sympathetic nerve dysfunction
US6865423B2 (en) Stimulation of muscles
US4456012A (en) Iontophoretic and electrical tissue stimulation device
US5117826A (en) Combined nerve fiber and body tissue stimulation apparatus and method
US5063929A (en) Electronic stimulating device having timed treatment of varying intensity and method therefor
US7636603B1 (en) Bionic ear implant
EP0268366B1 (en) Methods of and apparatus for generating low frequency electrical stimulus signals
CA2061732C (en) Combined nerve fiber and body tissue stimulation
US6671557B1 (en) System and method for providing percutaneous electrical therapy
US20030036780A1 (en) Treatment of movement disorders by near-diaphragmatic nerve stimulation
US4431002A (en) Modulated deep afferent stimulator
EP0111229A2 (en) Electric nerve stimulator device
US20030045922A1 (en) Skin treatment method and apparatus
GB2123698A (en) Biological electrical stimulators
US4453548A (en) Method of improving sensory tolerance with modulated nerve stimulator
US8233989B1 (en) System and method for fitting a hearing prosthesis sound processor using alternative signals
US4690146A (en) Neuromuscular stimulating apparatus
US4442839A (en) Method of modulating energy in train of electrical pulses
EP0099662A1 (en) Transcutaneous electrical nerve stimulation apparatus
RU2128529C1 (en) Multichannel stimulator

Legal Events

Date Code Title Description
AS Assignment

Owner name: MEDTRONIC, INC., 3055 OLD HIGHWAY EIGHT, MINNEAPOL

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST.;ASSIGNOR:RISE MARK T.;REEL/FRAME:003882/0340

Effective date: 19810430

Owner name: MEDTRONIC, INC., MINNESOTA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:RISE MARK T.;REEL/FRAME:003882/0340

Effective date: 19810430

STCF Information on status: patent grant

Free format text: PATENTED CASE

CC Certificate of correction
CC Certificate of correction
MAFP Maintenance fee payment

Free format text: PAYMENT OF MAINTENANCE FEE, 4TH YEAR, PL 96-517 (ORIGINAL EVENT CODE: M170); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

Year of fee payment: 4

FEPP Fee payment procedure

Free format text: SURCHARGE FOR LATE PAYMENT, PL 96-517 (ORIGINAL EVENT CODE: M176); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

MAFP Maintenance fee payment

Free format text: PAYMENT OF MAINTENANCE FEE, 8TH YEAR, PL 96-517 (ORIGINAL EVENT CODE: M171); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

Year of fee payment: 8

FEPP Fee payment procedure

Free format text: MAINTENANCE FEE REMINDER MAILED (ORIGINAL EVENT CODE: REM.); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

FEPP Fee payment procedure

Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

MAFP Maintenance fee payment

Free format text: PAYMENT OF MAINTENANCE FEE, 12TH YEAR, LARGE ENTITY (ORIGINAL EVENT CODE: M185); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

Year of fee payment: 12